Filing Details

Accession Number:
0001209191-17-048790
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-14 17:12:54
Reporting Period:
2017-08-11
Filing Date:
2017-08-14
Accepted Time:
2017-08-14 17:12:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Cascadian Therapeutics Inc. CASC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356256 Dunseth Scott Myers C/O Cascadian Therapeutics, Inc.
2601 4Th Ave., Suite 500
Seattle WA 98121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-11 5,500 $3.74 49,716 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.728 to $3.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.